Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.
Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.2%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference0.9%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSeveral links related to leukemia and clinical trials have been removed, including resources from MedlinePlus and NIH, which may impact access to important medical information.SummaryDifference2%
- Check36 days agoChange DetectedNew resources related to leukemia, including specific pages on acute myeloid leukemia and treatment drugs like Cytarabine and Daunorubicin, have been added to the website.SummaryDifference0.2%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.